David Greene

CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q

Seeking Alpha distributes articles at their discretion. My recent CTT report may have been over the proscribed word count recommendation. Upcoming articles on CTT will be within the word limits to encourage the Seeking Alpha publishers to disseminate the reports to Yahoo Finance.

Competitive Technologies Issues Another Stunning Press Release

Have you been following the progress at CTT, Mr. Furman? They have already announced the sale of 70 units--so it looks like their current quarter could conceivably have revenue for 53 units recognized.

And the clinical trials on the clinical data for patients suffering from Chemotherapy-induced neurapathy started in May. It seems that 6 months would be plenty of time to compile results in a non-invasive trial.

For a company with only about 10 million outstanding, CTT really has all the hallmarks of having a substantial run up in price once they start reporting the revenue increases quarter by quarter. Chronic pain management is a HUGE market--mostly dominated by prescription drugs. But many patients do not respond well to these drugs--and non-invasive treatment would be well-received.

The institutional ownership is gravy---if the sales ramp up like I believe they will, any substantial long term investment buying by the institutions would reduce the real world public float and the demand could get CTT over $5.00/share rather quickly. And the market cap at that price would still be only $50 Million.

Curious about your opinion--or if you are planning to do another report on CTT. Thanks in advance.

DG

Can the Greenback Rebound in 2008?

Judging by the sharp increase in the value of the dollar today, a trend reversal may be in the offing. Currency trading speculators have become complacent on riding the wave and most likely are more exposed than they would prefer as the "inevitable" decline in the dollar no longer looks like it will continue. President Bush will, IMO, jawbone for a strengthening dollar--further exacerbating the positions of currency traders that had bet on a tanking dollar. One day does not make a trend, but the possibility of a shift in the outlook for the dollar will certainly help the U.S.'s inflation picture.

High Tide for SiRF Technology

The investment thesis for SIRF in the near term is that the selling has swung too harshly to the downside as the "herd' has moved out of the stock. However, new investors/traders will take positions as the stock begins to turn. The fundamentals, in my opinion, make SIRF a low risk investment right now. But I am not investing for two years--I look to invest for short term to one year. I am content with 30-50% returns --and the sooner the better.

SIRF has a rather substantial short interest of 15,984,072 as of 1/31/2008. Once the selling abates and the short sellers begin to see their profits start to wither, short covering will begin in earnest.